Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Jul 29, 2005

SEC Form 4/A — Form 4/A

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-21

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-07-21	Common Stock, $0.01 Par Value	S	3650	$0.79	Disposed	12006896	Indirect
2005-07-21	Common Stock, $0.01 Par Value	S	1350	$0.7902	Disposed	12005546	Indirect
2005-07-21	Common Stock, $0.01 Par Value	S	5098	$0.80	Disposed	12000448	Indirect
2005-07-22	Common Stock, $0.01 Par Value	S	20487	$0.79	Disposed	11979961	Indirect
2005-07-22	Common Stock, $0.01 Par Value	S	2000	$0.7902	Disposed	11977961	Indirect
2005-07-22	Common Stock, $0.01 Par Value	S	1513	$0.791	Disposed	11976448	Indirect
2005-07-22	Common Stock, $0.01 Par Value	S	1000	$0.80	Disposed	11975448	Indirect

Footnotes

F1: This amendment to the Form 4 originally filed on July 22, 2005 (the "Original Form 4") amends and restates the Original Form 4 in its entirety and is being filed solely to correct the amount of Targeted Genetics Corporation common stock beneficially owned by the reporting person. The Original Form 4 inadvertently overreported the reporting person's beneficial ownership of Targeted Genetics Corporation common stock by 25,000 shares.

F2: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA, Inc., fka Biogen, Inc.